Ferroptosis Regulator Information
General Information of the Ferroptosis Regulator (ID: REG10269)
Full List of the Ferroptosis Target of This Regulator and Corresponding Disease/Drug Response(s)
Lysophosphatidylserine lipase ABHD12
can regulate the following target(s), and cause disease/drug response(s). You can browse detail information of target(s) or disease/drug response(s).
Browse Target
Browse Disease
Browse Drug
Unspecific Target [Unspecific Target]
| In total 1 item(s) under this target | ||||
| Experiment 1 Reporting the Ferroptosis Target of This Regulator | [1] | |||
| Responsed Disease | Fibrosarcoma | ICD-11: 2B53 | ||
| Responsed Drug | DO264 | Investigative | ||
| Pathway Response | Fatty acid metabolism | hsa01212 | ||
| Ferroptosis | hsa04216 | |||
| Cell Process | Cell ferroptosis | |||
In Vitro Model |
HT-1080 cells | Fibrosarcoma | Homo sapiens | CVCL_0317 |
| SU-DHL-5 cells | Diffuse large B-cell lymphoma | Homo sapiens | CVCL_1735 | |
| Response regulation | DO264, a selective inhibitor of the lyso- and ox-phosphatidylserine (PS) lipase ABHD12, enhances ferroptotic death caused by RSL3 in fibrosarcoma cells, an inhibitor of the lipid peroxidase GPX4. | |||
Fibrosarcoma [ICD-11: 2B53]
| In total 1 item(s) under this disease | ||||
| Experiment 1 Reporting the Ferroptosis-centered Disease Response | [1] | |||
| Target Regulator | Lysophosphatidylserine lipase ABHD12 | Protein coding | ||
| Responsed Drug | DO264 | Investigative | ||
| Pathway Response | Fatty acid metabolism | hsa01212 | ||
| Ferroptosis | hsa04216 | |||
| Cell Process | Cell ferroptosis | |||
In Vitro Model |
HT-1080 cells | Fibrosarcoma | Homo sapiens | CVCL_0317 |
| SU-DHL-5 cells | Diffuse large B-cell lymphoma | Homo sapiens | CVCL_1735 | |
| Response regulation | DO264, a selective inhibitor of the lyso- and ox-phosphatidylserine (PS) lipase ABHD12, enhances ferroptotic death caused by RSL3 in fibrosarcoma cells, an inhibitor of the lipid peroxidase GPX4. | |||
DO264
[Investigative]
| In total 1 item(s) under this drug | ||||
| Experiment 1 Reporting the Ferroptosis-centered Drug Response | [1] | |||
| Drug for Ferroptosis | Inducer | |||
| Response Target | Unspecific Target | |||
| Responsed Disease | Fibrosarcoma | ICD-11: 2B53 | ||
| Pathway Response | Fatty acid metabolism | hsa01212 | ||
| Ferroptosis | hsa04216 | |||
| Cell Process | Cell ferroptosis | |||
In Vitro Model |
HT-1080 cells | Fibrosarcoma | Homo sapiens | CVCL_0317 |
| SU-DHL-5 cells | Diffuse large B-cell lymphoma | Homo sapiens | CVCL_1735 | |
| Response regulation | DO264, a selective inhibitor of the lyso- and ox-phosphatidylserine (PS) lipase ABHD12, enhances ferroptotic death caused by RSL3 in fibrosarcoma cells, an inhibitor of the lipid peroxidase GPX4. | |||
